Showing results (181-190 of 222) with videos related to
Sort By:
Pageof 23
Gut and Liver|October 1, 2021
Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel DiseaseJi Min Lee, Shu-Chen Wei, Kang-Moon Lee, et al.Insights Into Imaging|November 29, 2024
Identification of neural alterations in patients with Crohn's disease with a novel multiparametric brain MRI-based radiomics modelRuo-Nan Zhang, Yang-di Wang, Hai-Jie Wang, et al.Iscience|December 5, 2024
AI-based fingerprint index of visceral adipose tissue for the prediction of bowel damage in patients with Crohn's diseaseXuehua Li, Cicong Hu, Haipeng Wang, et al.European Radiology|January 5, 2020
Magnetisation transfer imaging adds information to conventional MRIs to differentiate inflammatory from fibrotic components of small intestinal strictures in Crohn's diseaseZhuang-Nian Fang, Xue-Hua Li, Jin-Jiang Lin, et al.Therapeutic Advances in Gastroenterology|September 12, 2022
Mesenteric abnormalities play an important role in grading intestinal fibrosis in patients with Crohn's disease: a computed tomography and clinical marker-based nomogramJixin Meng, Yitao Mao, Jie Zhou, et al.Iscience|April 28, 2025
Altered gut microbiome-metabolite interactions link intestinal inflammation severity and MR enterography abnormalities in Crohn's diseaseRuonan Zhang, Zhoulei Li, Li Huang, et al.Acta Pharmaceutica Sinica. B|March 5, 2025
Dual activation of GCGR/GLP1R signaling ameliorates intestinal fibrosis via metabolic regulation of histone H3K9 lactylation in epithelial cellsHan Liu, Yujie Hong, Hui Chen, et al.Insights Into Imaging|January 30, 2024
CT-based radiomics signature of visceral adipose tissue and bowel lesions for identifying patients with Crohn's disease resistant to infliximabYangdi Wang, Zixin Luo, Zhengran Zhou, et al.Gut|July 8, 2026
SMOC2 mediates GLI1+ mesenchymal cell-driven fibrostenosis and predicts postoperative recurrence in Crohn's diseaseDanshu Wang, Xiangyu Zhao, Qidi Yang, et al.Therapeutic Advances in Gastroenterology|June 20, 2022
The hospitalization burden of inflammatory bowel disease in China: a nationwide study from 2013 to 2018Yi-Ming He, Ren Mao, Gang Yuan, et al.Pageof 23